MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma

Cell

Volumn 86, Issue 4, 1996, Pages 543-552

  Eppert, Kolja ^b,c   Scherer, Stephen W ^a   Ozcelik, Hilmi ^b   Pirone, Rosa ^a   Hoodless, Pamela ^a   Kim, Hyeja ^b   Tsui, Lap Chee ^a,c   Bapat, Bharati ^b   Gallinger, Steven ^b   Andrulis, Irene L ^b,c,d   Thomsen, Gerald H ^e   Wrana, Jeffrey L ^a   Attisano, Liliana ^a,d  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CANCER GENETICS; CHROMOSOME 18Q; CHROMOSOME MAP; COLORECTAL CARCINOMA; GENE MAPPING; GENE MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 16044369574     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80128-2     Document Type: Article

References (45)

1. Attisano, L., Wrana, J.L., Montalvo, E., and Massagué, J. (1996). Activation of signaling by the activin receptor complex. Mol. Cell. Biol. 16, 1066-1073.
2. Bhushan, A., Lin, H.Y., Lodish, H.F., and Kintner, C.R. (1994). The transforming growth factor-β type II receptor can replace the activin type II receptor in inducing mesoderm. Mol. Cell. Biol. 14, 4280-4285.
3. Cárcamo, J., Weis, F.M.B., Ventura, F., Wieser, R., Wrana, J.L., Attisano, L., and Massagué, J. (1994). Type I receptors specify growth-inhibitory and transcriptional responses to TGFβ and activin. Mol. Cell Biol. 14, 3810-3821.
4. Cavenee, W.K., Dryja, T.P., Phillips, R.A., Benedict, W.F., Godbout, R., Gallie, B.L., Murphee, A.L., Strong, L.C., and White, R.L. (1983). Expression of the recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305, 779-784.
5. Chen, F., and Weinberg, R.A. (1995). Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor-β receptor kinases. Proc. Natl. Acad. Sci. USA 92, 1565-1569.
6. Cho, K.R., Oliner, J., Simons, J.W., Hedrick, L., Fearon, E.R., Preisinger, A.C., Hedge, P., Silverman, G.A., and Vogelstein, B. (1994). The DCC gene: structural analysis and mutations in colorectal carcinomas. Genomics 19, 525-531.
7. Chumakov, I.M., Rigault, P., Le Gall, I., Ballanne-Chantelot, C., Billault, A., Guillou, S., Soularue, P., Guasconi, G., Poullier, E., Gros, I., Belova, M., Sambucy, J.-L., Susini, L., Gervy, P., Gilbert, F., Beaufils, S., Bui, H., Massart, C., De Tand, M.-F., Dukasz, S., Lecoulant, S., Ougen, P., Perrot, V., Saumier, M., Soravito, C., Bahouavila, R., Cohen-Akenine, A., Barillot, E., Bertrand, S., Codani, J.-J., Caterina, D., Georges, I., Lacroix, B., Lucotte, G., Sahbatou, M., Schmit, C., Sangouard, M., Tubacher, E., Dib, C., Faure, S., Fizames, C., Gyapay, G., Millasseau, P., Nguyen, S., Muselet, D., Vignal, A., Morissette, J., Menninger, J., Lieman, J., Desai, T., Banks, A., Bray-Ward, P., Ward, D., Hudson, T., Gerety, S., Foote, S., Stein, L., Page, D.C., Lander, E.S., Weissenbach, J., Le Paslier, D., and Cohen, D. (1995). A YAC contig map of the human genome. Nature 377S, 175-297.
8. Fearon, E.R., Cho, K.R., Nigro, J.M., Kern, S.E., Simons, J.W., Ruppert, J.M., Hamilton, S.R., Preisinger, A.C., Thomas, G., Kinzler, K.W., and Vogelstein, B. (1990). Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247, 49-56.
9. Filmus, J., and Kerbel, R.S. (1993). Development of resistance mechanisms to the growth-inhibitory effects of transforming growth factor-β during tumor progression. Curr. Opin. Oncol. 5, 123-129.
10. Graff, J.M., Bansal, A., and Melton, D.A. (1996). Xenopus Mad proteins transduce distinct subsets of signals for the TGFβ superfamily. Cell 85, 479-487.
11. Hahn, S.A., Schutte, M., Shamsul Hoque, A.T.M., Moskaluk, C.A., da Costa, L.T., Rozenblum, E., Weinstein, C.L., Fischer, A., Yeo, C.J., Hruban, R.H., and Kern, S.E. (1996a). DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271, 350-353.
12. Hahn, S.A., Shamsul Hoque, A.T.M., Moskaluk, C.A., da Costa, L.T., Schutte, M., Rozenblum, E., Seymour, A.B., Weinstein, C.L., Yeo, C.J., Hruban, R.H., and Kern, S.E. (1996b). Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res. 56, 490-494.
13. Hoodless, P.A., Haerry, T., Abdollah, S., Stapleton, M., O'Connor, M.B., Attisano, L., and Wrana, J.L. (1996). MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 85, 489-500.
14. Hudson, T.J., Stein, L.D., Gerety, S.S., Ma, J., Castle, A.B., Silva, J., Slonim, D., Baptista, R., Kuglyak, L., Xu, S.-H., Hu, X., Colbert, A.M.E., Rosenberg, C., Reeve-Daly, M., Rozen, S., Hui, L, Wu, X., Vestergaard, C., Wilson, K.M., Bae, J.S., Maitra, S., Ganiastsas, S., Evans, C.A., DeAngelis, M.M., Ingalls, K.A., Nahf, R.W., Horton, L.T., OskinAnderson, M., Collymore, A.J., Ye,W., Kouyoumjian, V., Zemsteva, I.S., Tam, J., Devine, R., Courtney, D.F., Turner Renaud, M., Nguyen, H., O'Connor, T.J., Fizames, C., Faure, S., Gyapay, G., Dib, C., Morissette, J., Orlin, J.B., Birren, B.W., Goodman, N., Weissenbach, J., Hawkins, T.L., Foote, S., Page, D.C., and Lander, E.S. (1995). An STS-based map of the human genome. Science 270, 1945-1954.
15. Joslyn, G., Carlson, M., Thliveris, A., Albertsen, H., Gelbert, L., Samowitz, W., Groden, J., Stevens, J., Spirio, L., Robertson, M., Sargeant, L., Krapcho, K., Wolff, E., Burt, R., Hughes, J.P., Warrington, J., McPherson, J., Wasmuth, J., LePaslier, D., Abderrahim, H., Cohen, D., Leppert, M., and White, R. (1991). Identification of deletion mutations and three new genes at the familial polyposis locus. Cell 66, 601-613.
16. Kessler, D.S., and Melton, D.A. (1994). Vertebrate embryonic induction: mesodermal and neural patterning. Science 266, 596-604.
17. Kinzler, K.W., Nilbert, M.C., Su, L.K., Vogelstein, B., Bryan, T.M., Levy, D.B., Smith, K.J., Preisinger, A.C., Hedge, P., McKechnie, D., Finniear, R., Markham, A., Groffen, J., Boguski, M.S., Altschul, S.F., Horii, A., Ando, H., Miyoshi, Y., Miki, Y., Nishisho, I., and Nakamura, Y. (1991). Identification of FAP locus genes from chromosome 5q21. Science 253, 661-665.
18. Lennon, G.G., Auffray, C., Polymeropoulos, M., and Soares, M.B. (1996). The I.M.A.G.E. consortium: an integrated molecular analysis of genomes and their expression. Genomics 33, 151-152.
19. Liu, F., Hata, A., Baker, J., Doody, J., Cárcamo, J., Harland, R., Massagué, J. (1996). A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 381, 620-623.
20. Mahony, D., and Gurdon, J.B. (1995). A type I serine/threonine kinase receptor that can dorsalize mesoderm in Xenopus. Proc. Natl. Acad. Sci. USA 92, 6474-6478.
21. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R.S., Zborowska, E., Kinzler, K.W., Vogelstein, B., Brattain, M., and Willson, J.K.V. (1995). Inactivation of the Type II TGFβ receptor in colon cancer cells with microsatellite instability. Science 268, 1336-1338.
22. Massagué, J. (1996). TGFβ signaling: receptors, transducers and Mad proteins. Cell 85, 947-950.
23. Massagué, J., Attisano, L., and Wrana, J.L. (1994). The TGFβ family and its composite receptors. Trends Cell Biol. 4, 172-178.
24. Miyazono, K., ten Dijke, P., Ichijo, H., and Heldin, C.-H. (1994). Receptors for transforming growth factor-β. Adv. Immunol. 55, 181-220.
25. Nellen, D., Burke, R., Struhl, G., and Basler, K. (1996). Direct and long-range action of a DPP morphogen gradient. Cell 85, 357-368.
26. Newfeld, S.J., Chartoff, E.H., Graff, J.M., Melton, D.A., and Gelbart, W.M. (1996). Mothers against dpp encodes a conserved cytoplasmic protein required in DPP/TGFβ-responsive cells. Development 122, 2099-2108.
27. Park, K., Kim, S.-J., Bang, Y.-J., Park, J.-G., Kim, N.K., Roberts, A.B., and Sporn, M.B. (1994). Genetic changes in the transforming growth factor β (TGFβ) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGFβ. Proc. Natl. Acad. Sci. USA 91, 8772-8776.
28. Riggins, G.J., Thiagalingam, S., Rozenblum, E., Weinstein, C.L., Kern, S.E., Hamilton, S.R., Willson, J.K.V., Markowitz, S.D., Kinzler, K.W., and Vogelstein, B. (1996). MAD-related genes in the human. Nature Genet. 13, 347-349.
29. Roberts, A.B., and Sporn, M.B. (1993). Physiological actions and clinical applications of transforming growth factor-β (TGFβ). Growth Factors 8, 1-9.
30. Rupp, R.A., Snider, L., and Weintraub, H. (1994). Xenopus embryos regulate the nuclear localization of XMyoD. Genes Dev. 8, 1311-1323.
31. Savage, C., Das, P., Finelli, A., Townsend, S., Sun, C., Baird, S., and Padgett, R. (1996). The C. elegans sma-2, sma-3, and sma-4 genes define a novel conserved family of TGFβ pathway components. Proc. Natl. Acad. Sci. USA 93, 790-794.
32. Scherer, S.W., and Tsui, L-C. (1991). Cloning and analysis of large DNA molecules. In Advanced Techniques in Chromosome Research, K. Adolph, ed. (New York: Marcel Dekker, Inc.), pp. 33-72.
33. Sekelsky, J.J., Newfeld, S.J., Raftery, L.A., Chartoff, E.H., and Gelbart, W.M. (1995). Genetic characterization and cloning of Mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster. Genetics 139, 1347-1358.
34. Smith, J.C., Price, B.M.J., Green, J.B.A., Weigel, D., and Herrmann, B.G. (1991). Expression of a Xenopus homolog of Brachyury (T) is an immediate-early response to mesoderm induction. Cell 67, 79-87.
35. Thomsen, G.H. (1996). Xenopus mothers against decapentaplegic is an embryonic ventralizing agent that acts downstream of the BMP2/4 receptor. Development 122, 2359-2366.
36. Vogelstein, B., Fearon, E.R., Hamilton, S.R., Kern, S.E., Preisinger, A.C., Leppert, M., Nakamura, Y., White, R., Smits, A.M.M., and Bos, J.L. (1988). Genetic alterations during colorectal tumor development. N. Engl. J. Med. 319, 213-221.
37. Wall, N.A., and Hogan, B.L.M. (1994). TGFβ-related genes in development. Curr. Opin. Genet. Dev. 4, 517-522.
38. Walter, M., Spillet, D., Thomas, P., Weissenbach, J., and Goodfellow, P. (1994). A method for constructing radiation hybrid maps of whole genomes. Nature Genet. 7, 22-28.
39. Wiersdorff, V., Lecuit, T., Cohen, S.M., and Mlodzik, M. (1996). Mad acts downstream of Dpp receptors, revealing a differential requirement for dpp signaling in initiation and propagation of morphogenesis in the Drosophila eye. Development 122, 2153-2162.
40. Wieser, R., Wrana, J.L., and Massagué, J. (1995). GS domain mutations that constitutively activate TβR-I, the downstream signaling component in the TGFβ receptor complex. EMBO J. 14, 2199-2208.
41. Wilson, P.A., and Melton, D.A. (1994). Mesodermal patterning by an inducer gradient depends on secondary cell-cell communication. Curr. Biol. 4, 676-686.
42. Wrana, J.L., and Attisano, L. (1996). MADR-related (MADR) proteins in TGFβ signaling. Trends Genet., in press.
43. Wrana, J.L., Attisano, L., Cárcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X.-F., and Massagué, J. (1992). TGFβ signals through a heteromeric protein kinase receptor complex. Cell 71, 1003-1014.
44. Wrana, J.L., Attisano, L., Wieser, R., Ventura, F., and Massagué, J. (1994). Mechanism of activation of the TGFβ receptor. Nature 370, 341-347.
45. Yamaguchi, T., Toguchida, J., Yamamuro, T., Kotoura, Y., Takada, N., Kawaguchi, N., Kaneko, Y., Nakamura, Y., Sasaki, M.S., and Ishizaki, K. (1992). Allelotype analysis in osteosarcomas: frequent allele loss on 3q, 13q, 17p, and 18q. Cancer Res. 52, 2419-2423.